We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
(+14%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$200M |
| 2 |
Amazon
AMZN
|
+$126M |
| 3 |
Deutsche Bank
DB
|
+$109M |
| 4 |
Intuitive Surgical
ISRG
|
+$92.2M |
| 5 |
Wells Fargo
WFC
|
+$83.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$126M |
| 2 |
Abbott
ABT
|
+$79.1M |
| 3 |
VF Corp
VFC
|
+$49M |
| 4 |
JPMorgan Chase
JPM
|
+$48.5M |
| 5 |
BioNTech
BNTX
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.46% |
| 3 | Financials | 11.88% |
| 4 | Communication Services | 9.65% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Syndax Pharmaceuticals
SNDX
$1.82B
| $427K | ﹤0.01% |
25,000
| – | – |
|
1102
MacroGenics
MGNX
$259M
| $426K | ﹤0.01% |
16,200
| – | – |
|
1103
Armstrong World Industries
AWI
$7.75B
| $425K | ﹤0.01% |
3,983
-14,424
| -78% | -$1.49M |
|
|
RPTX
1104
DELISTED
Repare Therapeutics
RPTX
| $424K | ﹤0.01% |
12,900
| – | – |
|
1105
Codexis
CDXS
$161M
| $423K | ﹤0.01% |
18,000
| – | – |
|
1106
Kodiak Sciences
KOD
$2.72B
| $423K | ﹤0.01% |
4,760
| – | – |
|
1107
Atara Biotherapeutics
ATRA
$77.6M
| $419K | ﹤0.01% |
1,104
| – | – |
|
1108
Liberty Global Class A
LBTYA
$3.46B
| $418K | ﹤0.01% |
15,315
-2,956
| -16% | -$79.7K |
|
|
CGC
1109
Canopy Growth
CGC
$402M
| $417K | ﹤0.01% |
1,717
+367
| +27% | +$94K |
|
1110
Liberty Broadband Class A
LBRDA
$5.17B
| $416K | ﹤0.01% |
2,508
-1,341
| -35% | -$210K |
|
1111
ICL Group
ICL
$6.89B
| $406K | ﹤0.01% |
59,332
+2,706
| +5% | +$18.4K |
|
|
IMGN
1112
DELISTED
Immunogen Inc
IMGN
| $401K | ﹤0.01% |
62,000
| – | – |
|
1113
Akebia Therapeutics
AKBA
$234M
| $390K | ﹤0.01% |
102,100
| – | – |
|
1114
United Airlines
UAL
$40.2B
| $382K | ﹤0.01% |
7,335
| – | – |
|
1115
HEICO Corp
HEI
$50.9B
| $380K | ﹤0.01% |
2,743
-477
| -15% | -$65.8K |
|
|
CCXI
1116
DELISTED
ChemoCentryx, Inc.
CCXI
| $374K | ﹤0.01% |
27,100
| – | – |
|
1117
Ovintiv
OVV
$17.6B
| $372K | ﹤0.01% |
12,000
| – | – |
|
1118
Korea Electric Power
KEP
$15.7B
| $369K | ﹤0.01% |
34,974
| – | – |
|
1119
Toro Company
TTC
$9.4B
| $369K | ﹤0.01% |
3,405
| – | – |
|
|
KLRS
1120
Kalaris Therapeutics
KLRS
$93.7M
| $369K | ﹤0.01% |
826
| – | – |
|
1121
Teradata
TDC
$2.58B
| $366K | ﹤0.01% |
7,251
+2,457
| +51% | +$112K |
|
1122
Karyopharm Therapeutics
KPTI
$44.4M
| $364K | ﹤0.01% |
2,413
| – | – |
|
1123
AerCap
AER
$23.5B
| $356K | ﹤0.01% |
7,057
+4,361
| +162% | +$252K |
|
1124
RB Global
RBA
$17.4B
| $356K | ﹤0.01% |
6,078
+396
| +7% | +$24.4K |
|
1125
Sensient Technologies
SXT
$5.51B
| $353K | ﹤0.01% |
+4,161
| New | +$353K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review
As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
- DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
- DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
- DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.